Search

In a string of recent merger decisions, culminating in the Dow/DuPont case, the European Commission has profoundly revisited its traditional analysis of innovation and, ultimately, introduced what some authors have labeled "a novel theory of harm in EU merger policy." According to this theory, the Commission does not look at harm to innovation on a specific product market in which parties are developing similar pipeline products, but adopts a general assessment of harm to innovation, unrelated to a specific product market and without considering potential anticompetitive effects on this basis. The purpose of this article is to show that over the last few years, the European Commission has been progressively departing from a "traditional" theory of harm in its assessment of mergers affecting innovation. In particular, we argue that the novel theory of harm developed in Dow/DuPont, based on a generic prejudice to innovation, is the landing place of a long journey through which the Commission has progressively altered the analytical framework applicable to traditional cases affecting pipeline products/potential competitors. And while this stance may be inspired by a legitimate policy goal, it brings the Commission on a collision route with the principles of causation and symmetry governing European Union merger control analysis. [ABSTRACT FROM AUTHOR]

In the Dubovac crematory, the urn containing cremated human bone fragments was submitted to anthropological analysis. The bone fragments were cleaned and identified according to standard procedures. The results showed the following: the total weight of the bone fragments was 550 g. Of a total of over 860 bone fragments, 700 could not be identified as they were too small. The most representative fragments belonged to the skull bones: frontal, parietal, sphenoid, occipital, zygomatic, mandible. Only some small fragments remained from the long bones: part of the femoral diaphysis, the lower half of an ulna, the upper half of a radius, as well as parts of phalanges and talus. As a conclusion, the findings have shown that the bone fragments belonged to a single female individual. Growth cartilage ossification indicates an age of about 30 years. [ABSTRACT FROM AUTHOR]